|
EYPT Eyepoint Pharmaceuticals Inc 1314102 |
| Balance Sheet |
|
Current Assets
|
383,306,000 |
|
Assets
|
418,465,000 |
|
Current Liabilities
|
49,048,000 |
|
Liabilities
|
81,964,000 |
|
Equity
|
336,501,000 |
|
Shares Out
|
53,518,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-126,226,000 |
|
Investing Cash Flow
|
-219,355,000 |
| Market Analysis |
Market Cap
|
567,828,083 |
|
BVPS
|
6.29 |
|
PB
|
0.97 |
|
EPS
|
-1.80 |
|
PS
|
3.28 |
|
FCF
|
-345,581,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view EYPT documents filed with the SEC.
EYPT Filings
Clear
